CABIOĞLU, N. Et Al. 2021. Tim3 expression on tumor infiltrating lymphocytes is associated with poor response to neoadjuvan chemotherapy in patients with locally advanced triple negative breast cancer. CANCER RESEARCH , no.4 .

CABIOĞLU, N., ÖNDER, S., Oner, G., Karatay, H., TÜKENMEZ, M., Muslumanoglu, M., ... Igci, A.(2021). Tim3 expression on tumor infiltrating lymphocytes is associated with poor response to neoadjuvan chemotherapy in patients with locally advanced triple negative breast cancer. CANCER RESEARCH , no.4.

CABIOĞLU, Neslihan Et Al. "Tim3 expression on tumor infiltrating lymphocytes is associated with poor response to neoadjuvan chemotherapy in patients with locally advanced triple negative breast cancer," CANCER RESEARCH , no.4, 2021

CABIOĞLU, Neslihan Et Al. "Tim3 expression on tumor infiltrating lymphocytes is associated with poor response to neoadjuvan chemotherapy in patients with locally advanced triple negative breast cancer." CANCER RESEARCH , no.4, 2021

CABIOĞLU, N. Et Al. (2021) . "Tim3 expression on tumor infiltrating lymphocytes is associated with poor response to neoadjuvan chemotherapy in patients with locally advanced triple negative breast cancer." CANCER RESEARCH , no.4.

@article{article, author={Neslihan CABIOĞLU Et Al. }, title={Tim3 expression on tumor infiltrating lymphocytes is associated with poor response to neoadjuvan chemotherapy in patients with locally advanced triple negative breast cancer}, journal={CANCER RESEARCH}, year=2021}